The video window is being blocked by your browser.
Please try accessing from an alternative browser or device
Join the conversation...
Please type your questions below during the broadcast... Click 'Open Q&A'
Alternatively scan the above QR code with your device's camera
Please note that all questions submitted will be moderated by Novartis to align with compliance and industry standards.
This meeting is organised and funded by Novartis Pharmaceuticals UK Ltd and is classed as promotional under the Association of the British Pharmaceutical Industry (ABPI) Code. It is intended for GB healthcare professionals only.
Company products will be discussed at this meeting and Great Britain prescribing information is available above.
UK | September 2023 | 294952
Your attendance at the event is governed by our Healthcare Professional Event Attendance Terms. By attending the event, you are agreeing to be bound by such terms.
Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard (UK).
Adverse events should also be reported to Novartis via uk.patientsafety@novartis.com or online through the pharmacovigilance intake (PVI) tool at www.novartis.com/report
If you have a question about a product, please contact Medical Information on 01276 698370 or by email at medinfo.uk@novartis.com